The Williams-Beuren syndrome is a rare genetic disorder caused by a microdeletion of chromosome 7q11.23, characterized by a complex and multisystemic clinical picture including congenital heart disease (typically supravalvular aortic or pulmonary artery stenosis), associated with mild-to-moderate intellectual disability, characteristic facial phenotype (“elfin face”), peculiar behavioral profile, and connective tissue abnormalities. The syndrome was first described in 1961 by J.C.P. Williams and in 1962 by Alois Beuren. It affects both sexes, with an estimated prevalence of 1:7,500–10,000 live births, and is today one of the most studied models of genotype–phenotype correlation in the field of rare diseases.
The etiology of Williams-Beuren syndrome is due to a submicroscopic microdeletion of about 1.5–1.8 Mb at 7q11.23 on chromosome 7, involving 26–28 contiguous genes. This deletion occurs de novo in 85–95% of cases, while autosomal dominant familial transmission is rare (5–10%). The most important gene involved in the clinical picture is ELN (elastin), whose loss is directly responsible for the vascular manifestations.
The direct causes of the syndrome are:
Risk factors that cannot be modified include advanced parental age (more commonly described for trisomies, but also as a minor risk factor here) and a family history of genomic microdeletions, but in the majority of cases the syndrome arises sporadically and is not preventable.
From a pathogenetic point of view, the loss of the ELN gene leads to elastin deficiency in the vessel walls and connective tissues, resulting in abnormal vascular development and the typical picture of supravalvular aortic stenosis (SVAS) or pulmonary artery stenosis, often multiple. The absence of elastin makes the arterial walls more rigid and predisposed to intimal thickening, smooth muscle cell proliferation and progressive narrowing of the vascular lumen.
The deletion also involves genes such as LIMK1 and GTF2I, essential for neurological development and cognitive and social functions. These genetic deficits lead to abnormal neuronal migration, synaptic connection defects and alterations in neurocognitive circuits, affecting learning, language, attention and the hypersocial behavioral profile typical of the syndrome.
From a pathophysiological perspective, Williams-Beuren syndrome is a connective tissue disease with multisystemic expression:
The progressive alteration of connective tissue, associated with elastin deficiency and other molecular deficits, underlies most of the clinical manifestations and long-term complications, making the syndrome a paradigm of multisystemic genetic disease.
The clinical presentation of Williams-Beuren syndrome is extremely variable and reflects the complex interplay between genetic deficits, connective tissue abnormalities, vascular, neurocognitive and behavioral anomalies. The onset of symptoms usually occurs in childhood, but many features can be evident in the neonatal period or in the first months of life. The picture evolves over time, with multisystemic involvement affecting the cardiovascular system, central nervous system, skeletal, renal, gastrointestinal systems, as well as the skin and sensory organs.
In newborns and infants, one of the earliest clinical signs is supravalvular aortic stenosis (SVAS), present in 75–80% of patients and considered the pathognomonic marker of the syndrome. It may be associated with a systolic heart murmur detectable at birth or within the first weeks, sometimes accompanied by pulmonary artery stenosis (often multiple and variable in severity) or other large vessels such as the renal arteries.
During the first years of life, transient hypercalcemia, marked irritability, vomiting, constipation and delayed growth may appear. Neonatal hypercalcemia presents with lethargy, hypotonia, seizures and risk of nephrocalcinosis, requiring careful monitoring and management.
From a craniofacial point of view, children with Williams-Beuren syndrome show a characteristic facial appearance (“elfin face”), with broad forehead, flat nasal bridge, full lips with wide mouth, full cheeks, pointed chin, short palpebral fissures and epicanthal folds. These features tend to become more pronounced with age.
With growth, abnormal body proportions (short stature, short trunk compared to limbs), joint hypermobility, scoliosis and thoracic deformities become evident. The skin often appears loose, with a tendency to fold, premature wrinkling and fragility of soft tissues. Inguinal and umbilical hernias are frequent.
From a neuropsychological point of view, the syndrome is characterized by mild-to-moderate intellectual disability, with an average IQ between 50 and 70. The cognitive profile shows a marked dissociation between verbal skills (often relatively preserved or even outstanding) and profound visuospatial deficits, which affect school learning and daily activities. Many patients develop above-average short-term verbal memory, but have significant difficulties with abstract reasoning, planning and spatial orientation.
The behavioral profile is unique and distinctive: patients exhibit hypersociability, excessive friendliness, ease in establishing relationships even with strangers, accentuated but often superficial empathy, and marked emotional sensitivity. Generalized anxiety, tendency to phobias (especially to loud sounds), hyperactivity, attention deficit and, in a minority, autistic spectrum traits are also observed.
From a cardiovascular standpoint, besides supravalvular aortic stenosis, arterial hypertension, stenosis of the pulmonary or renal arteries, mitral valve prolapse and, rarely, cerebral artery aneurysms may occur. These conditions may cause dyspnea, chest pain, syncope or, more rarely, acute cerebrovascular events.
Ocular manifestations include hypermetropia (often severe), strabismus, retinal artery stenosis and, in some cases, juvenile cataract. Auditory abnormalities include sensorineural hearing loss of varying degree.
Among the systemic manifestations are:
Physical examination highlights typical facial traits, murmur from stenosis, dysmorphic skeletal features, loose skin and possible gingival hypertrophy. Careful multidisciplinary assessment allows the full complexity of the disorder to be appreciated, guiding diagnostic and therapeutic pathways.
Diagnosis of Williams-Beuren syndrome is based on a combination of clinical criteria, phenotypic characteristics, multisystemic manifestations and, above all, genetic-molecular confirmation. Clinical suspicion typically arises in the presence of specific congenital heart disease (particularly supravalvular aortic stenosis), together with characteristic facial phenotype, mild-to-moderate intellectual disability and hypersociability. The heterogeneity of clinical presentations can sometimes delay recognition of the syndrome, especially in early infancy.
The diagnostic process should follow a progressive and rational approach. Initially, a thorough medical history and physical examination can reveal key signs: heart murmur, peculiar facies, hypercalcemia, ocular anomalies, growth retardation, behavioral features. In neonatal or pediatric age, finding vascular stenoses or unexplained hypercalcemia may already direct suspicion towards the diagnosis.
The main instrumental tests include:
Laboratory tests are indicated for:
Molecular diagnosis is the gold standard and is essential for definitive confirmation. It is performed using fluorescence in situ hybridization (FISH) or, more recently, CGH microarray or MLPA, which can detect the specific deletion in the 7q11.23 region of chromosome 7, even in atypical cases. Genetic counseling is recommended for every patient and family member.
Differential diagnosis includes other conditions with facial dysmorphisms, cognitive deficits and congenital heart disease, such as Noonan syndrome, DiGeorge syndrome (22q11.2), Alagille syndrome, some forms of mucopolysaccharidosis, and cardio-facio-cutaneous phenotype. However, the combination of typical facies, supravalvular aortic stenosis, hypersociability and dissociated cognitive profile is highly suggestive for Williams-Beuren syndrome.
Multidisciplinary follow-up is essential: it includes periodic cardiological evaluations, monitoring of calcium metabolism, nephrological, endocrinological, ophthalmological, ENT and neuropsychiatric assessments, as well as careful educational and rehabilitative support. Early diagnosis and precise definition of associated abnormalities allow prompt therapeutic management and prevention of serious complications.
Management of Williams-Beuren syndrome requires a multidisciplinary and personalized approach, targeting both the major clinical manifestations and the prevention and management of multisystemic complications. There is no causal therapy able to correct the genetic microdeletion; therefore, treatment is directed at the individual organs and systems involved, adapting therapeutic and rehabilitative strategies to the clinical picture and patient’s age.
Treatment of congenital heart disease is the clinical priority in the management of the syndrome. Supravalvular aortic stenosis is monitored by regular echocardiographic checks and treated surgically only in the case of significant hemodynamic severity or onset of symptoms (dyspnea, syncope, chest pain, left ventricular failure). In the presence of multiple stenoses of the pulmonary or renal arteries, angioplasty or targeted interventional procedures may be required. However, vascular surgery in these patients carries increased risks due to tissue fragility and the possible presence of other undetected vascular anomalies.
Management of hypercalcemia in neonates and young children involves dietary restriction of calcium and vitamin D, adequate hydration, possible use of hypocalcemic drugs and frequent monitoring of serum levels. Most patients outgrow the phase of hypercalcemic risk as they grow, but monitoring remains essential to prevent nephrocalcinosis and renal damage.
Neuropsychological and educational treatment is fundamental and should begin early. It includes cognitive rehabilitation, speech therapy, psychomotricity, behavioral interventions for anxiety and adaptation difficulties. Educational support must be individualized, aiming to enhance verbal and relational abilities, compensating for visuospatial and attentional deficits.
For systemic manifestations specialist assessments and treatments are required:
Psychological support for patients and families is crucial, both to face the emotional impact of the diagnosis and to manage the social and relational difficulties related to the typical behavioral profile of the syndrome.
The prognosis of Williams-Beuren syndrome is variable and mainly depends on the severity of congenital heart disease and vascular complications. Patients who survive early childhood without severe cardiovascular events can have a good life expectancy, although they require regular follow-up and continuous monitoring of organ functions. Neurocognitive and behavioral complications can limit autonomy, but quality of life is often preserved thanks to early rehabilitation, cooperation among specialists, and school and social inclusion. Early diagnosis, global care and multidisciplinary follow-up remain the main positive prognostic factors.
Williams-Beuren syndrome carries a high risk of complications, which may occur at any stage of life and involve numerous organs and systems. Prevention, early identification and timely management of these complications are essential to reduce morbidity and improve prognosis.
The risk of serious complications makes regular monitoring, collaboration among specialists from different fields and active family participation in the care process essential, in order to ensure the best possible quality of life and prompt management of emergencies.